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We discuss the complex eco-social factors involved in the puzzle of the unexpected rapid viral spread in the ongoing 
Brazilian yellow fever (YF) outbreak, which has increased the reurbanisation risk of a disease without urban cases in Brazil since 
1942. Indeed, this rapid spatial viral dissemination to the Southeast and South regions, now circulating in the Atlantic Forest 
fragments close to peri-urban areas of the main Brazilian megalopolises (São Paulo and Rio de Janeiro) has led to an exponential 
increase in the number of yellow fever cases. In less than 18 months, 1,833 confirmed cases and 578 deaths were recorded 
most of them reported in the Southeast region (99,9%). Large epizooties in monkeys and other non-human primates (NHPs) 
were communicated in the country with 732 YF virus (YFV) laboratory confirmed events only in the 2017/2018 monitoring 
period. We also discuss the peculiarities and similarities of the current outbreak when compared with previous great epidemics, 
examining several hypotheses to explain the recent unexpected acceleration of epizootic waves in the sylvatic cycle of the YFV 
together with the role of human, NHPs and mosquito mobility with respect to viral spread. We conclude that the most feasible 
hypothesis to explain this rapidity would be related to human behavior combined with ecological changes that promoted a 
significant increase in mosquito and NHP densities and their contacts with humans. We emphasize the urgent need for an 
adequate response to this outbreak such as extending immunisation coverage to the whole Brazilian population and developing 
novel strategies for immunisation of NHPs confined in selected reserve areas and zoos. Finally, we stress the urgent need to 
improve the quality of response in order to prevent future outbreaks and a catastrophic reurbanisation of the disease in Brazil and 
other South American countries. Continuous monitoring of YFV receptivity and vulnerability conditions with effective control 
of the urban vector Aedes aegypti and significant investments in YF vaccine production capacity and research and development 
for reduction of adverse effects are of the highest priority.
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Brazilian authorities and scientists have reported 
with perplexity the worst outbreak of sylvatic yellow fe-
ver (YF) in the last 80 years in the country with an ex-
ponential increase in the number of confirmed cases and 
deaths in humans and epizootics in non-human primates 
(NHPs). The ongoing outbreak spread from November 
2016 into forest areas contiguous to the country’s larg-
est megalopolises in the Southeast region, such as São 
Paulo and Rio de Janeiro, significantly increasing the 
risk of reurbanisation of the disease. There are complex 
eco-social determinants of this rapid YF viral spread, 
but also policy constraints and erroneous strategies 
certainly have contributed to accelerate and aggravate 
this epidemiological scenario. The goal of minimis-
ing the risk of resurgence of urban YF in Brazil, a dis-
ease eliminated in 1942, is theoretically achievable and 
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would require simply immunisation of all the Brazilian 
population with the highly effective YF vaccine prefer-
ably combined with reduction of Aedes aegypti infesta-
tion indexes. Nevertheless, from a practical perspective, 
the pathway to achieve this goal has been permeated by 
erroneous policies and strategies: (1) negligence in early 
detection and reporting of epizootics in YF virus (YFV) 
emergence as well as surveillance in non-endemic ar-
eas in 2016; (2) delayed immunisation response from 
the Brazilian authorities with very low vaccine cover-
age which has resulted in an extremely high incidence 
of the disease in rural and peri-urban areas, thus leading 
to an exponential increase in the demand for vaccines; 
(3) concentration of YF immunisation on children, leav-
ing uncovered the adult population which is generally 
the most affected by the sylvatic YF outbreaks; (4) de-
lay in reaching and providing YF immunisation for ru-
ral workers living close to forest areas and eco-tourists, 
more exposed to the YFV; (5) failure in social communi-
cation on the effectiveness of the YF vaccine and dealing 
with vaccination refusal consequent to an exacerbated 
perception of its adverse effects; and finally (6) very low 
sanitation coverage (< 50% of the Brazilian population) 
together with failure in Ae. aegypti and Ae. albopictus 
control, enhancing the risk of YFV re-urbanisation.
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We provide epidemiological information and scien-
tific evidence on the complexity of this scenario and 
emphasize the urgent need to intensify human immuni-
sation coverage by increasing vaccine availability and 
implementing campaigns with solid communication in-
terventions to preclude stagnation of coverage levels. We 
also emphasize the urgency to develop innovative strate-
gies, as vaccinating NHPs, especially endemic and en-
dangered species confined in preservation areas, avoid-
ing their extinction and reducing their potential role as 
local YFV amplifiers. Although controversies among 
primatologists on the feasibility of NHP immunisation 
have emerged due to potential difficulties in capturing 
and/or injecting vaccine in free-living animals in the 
open field owing to their high mobility, novel techno-
logical strategies for monkey immunisation, preserving 
biodiversity in Brazil, should be conceived and evaluat-
ed. Some of these novel strategies are suggested herein.
YF epidemiology: rapid viral spread and emergency
There has historically been a consensus among scien-
tists and policy makers in Brazil that YFV transmission 
would probably remain confined to sylvatic cycles in ar-
eas with low population densities and with a low number 
of annual cases as in the past since the last urban case 
in 1942. Nevertheless, environmental, eco-social and hu-
man behavioral changes in the last decades have created 
conditions for an exponential increase in YF cases and 
case fatalities in the country during the ongoing outbreak 
(Fig. 1), in which the risk for reurbanisation of the dis-
ease has significantly amplified. Indeed, since Novem-
ber 2016, after decades of silence, the YFV has spread 
into the coastal Atlantic Forest zones and rapidly moved 
into the Southeast and South of the country, reaching 
in less than one year four of the most populous Brazil-
ian states (Minas Gerais, São Paulo, Rio de Janeiro and 
Espírito Santo) whose residents had not been included 
in the YFV vaccination program. The low vaccination 
coverage of potential risk areas in these highly populated 
states has resulted in a sharp increase in the number of 
YF cases in the country: 1,833 confirmed cases and 578 
deaths were recorded in less than 18 months. A total of 
1257 confirmed cases and 394 deaths were reported up to 
EW17 (April 28 2018) in the monitoring period 2017/2018 
(July 1 to June 30).(1) This number is much higher than 
that reported for the same period of 2016/2017 with 576 
confirmed cases including 184 deaths and contrasts with 
the very low number of human cases and epizootics in 
the respective monitoring period in 2015 when three YF 
human cases were confirmed in the country with two 
deaths. Finally, it should be noted that early reports of 
YF cases in the 1930-1950s in Brazil were concentrated 
on case fatalities, so examining the evolution of lethality 
rate up to 2017 would be misleading.
Moreover, it should be emphasised that evidences of 
the emergence of the current YFV transmission wave 
were recorded as early as in July 2014, with confirmed 
epizooties in the transition area between the Amazon 
and Cerrado, a savanna-like biome, in Tocantins state; 
in 2015 the Ministry of Health(2) reported a change in the 
pattern of sylvatic YF outbreak dissemination in Brazil 
in the seasonal period 2014/2015 with 100 confirmed hu-
man cases and 51% lethality in the Cerrado, in the mid-
west states of Goiás and Mato Grosso do Sul, in touristic 
areas with an intense flow of people in the summer. Fig. 
2 illustrates the rapid dislocation of YFV to other Brazil-
ian biomes and recent reintroduction into the Southeast 
and Atlantic Forest in the ongoing outbreak.
YF epizootics: multiple pathways  
in viral dislocation
Large epizooties in NHPs have recently been reported 
in Brazil with 732 YFV laboratory confirmed events in 
the 2017/2018 monitoring period up to EW 17 (April 28 
2018). Epizootics exponentially increased in Brazil in six 
states (Espírito Santo, Mato Grosso, Minas Gerais, Rio 
de Janeiro, São Paulo and Tocantins) indicating sustained 
viral circulation in the pre-seasonal and seasonal periods 
with São Paulo state accounting for 42% of the total con-
firmed epizootics.(1) It is interesting to compare the current 
Fig. 1: yellow fever: human cases and case fatalities in Brazil 1930-2017. Source: Brazilian Ministry of Health, YF Epidemiological reports 1930-2018.
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outbreak with those in the past. The last severe YFV epi-
demics in Brazil occurred in 1934-1940, which were com-
prised of essentially sylvatic cases but also urban trans-
mission with 1,079 confirmed deaths by histopathology.
A comparative analysis contrasting the epidemics 
of 1934-1940 with that of 2016-2018 allows the identi-
fication of important differences in the patterns of YFV 
spread: (1) the lower human population density in the re-
gion in 1934-40 versus a much larger population in 2016-
2018. The population in the Southeast augmented 368% 
from 18,345 (19.8 people/km2) to 85,817 thousand inhab-
itants (92.9/km2) between 1940 to 2015;(3,4)(2) still no use 
of the vaccine for the most part (or totally unused at the 
beginning) of the epidemic due to unavailability at that 
time (the first use was in 1937) versus availability of a 
highly effective vaccine produced in Brazil in 2016-2018 
which is in contrast to the rapid dissemination of the dis-
ease; and (3) underreporting of cases in 1934-1940 since 
the diagnostic criteria were histopathology the numbers 
of deaths and cases are the same in the historical tables 
of Franco(5) and Benchimol(6) in 1934-1940 versus the 
use of other diagnostic criteria such as polymerase chain 
reaction (PCR) in 2016-2018. Fig. 3 shows the route of 
spatial viral dislocation considering both epizootics and 
recorded YF human cases during the 1934-1940 in South 
and Southeast regions(7) essentially the same touched by 
the ongoing outbreak. This previous outbreak also fol-
lowed multiple pathways in epizootic waves originating 
from the inland Cerrado biome (mostly from the states of 
Goiás and Minas Gerais) and reaching the Atlantic forest 
biome in the coastal states of São Paulo, Espírito Santo, 
Rio de Janeiro, similar to that of 2016-2018.(8-10)
Although the epizootic waves had propagated in the 
1934-1940 outbreak with lower intensity and velocity 
than in 2016-2018, it is interesting to note the similari-
ties between both outbreaks in spatial dislocation pat-
terns following multiple pathways.
Factors: unusual dislocation and rapidity  
of YF outbreak
The perplexity with the current epidemiological 
scenario of the YF outbreak originates from insuf-
ficient knowledge on the conditions favoring YFV re-
emergence and its very rapid spread from North and 
Mid-West endemic regions into the coastal Southeastern 
more populated areas. The dissemination of the YFV as 
a re-emerging threat in the Americas and the increasing 
risk of reurbanisation of the disease(11-14) has multifacto-
rial origins and cannot be attributed to just one cause. 
A modelling study(15) has examined these multiple fac-
tors and the risk of urban YF resurgence in Ae. aegypti-
infested American cities. Several hypotheses have been 
considered for the YFV re-emergence in Brazil:
Viral mutations and evolution - A recent genome anal-
ysis of the circulating YFV in the ongoing outbreak has 
confirmed that it belongs to the South American genotype 
I modern lineage and a sublineage, named 1E, which prob-
ably independently disseminated from Venezuela into the 
Brazilian Amazon and then into the inland Centre-West 
Fig. 2: yellow fever virus spread:  rapid dislocation into and between Brazilian biomes. Black dashed line: viral spread from late 1980’ until 2010; 
white line: viral spread from the first half of the 2010 decade onward, including the ongoing outbreak in the Southeast. Sources: IBGE/MMA 2004 
for map of Brazilian biomes. Brazilian Ministry of Health//SVS, YF reports from 1999-2018 for epidemiological information on epizootic waves 
and human cases (http://portalms.saude.gov.br/saude-de-a-z/febre-amarela-sintomas-transmissao-e-prevencao/situacao-epidemiologica-dados).
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and Southeast (estimated to have taken place around 2005) 
and South (causing the 2008-2009 outbreak).(16) The current 
Brazilian outbreak would be caused by an independent vi-
ral dissemination from Northern South America Venezu-
ela into Southeastern Brazil.(10,16) Intriguingly, it was iden-
tified that the YFV circulating in the 2016-2018 outbreak 
has a distinct molecular signature with unique amino acid 
substitutions mostly located in highly conserved positions 
in non-structural protein mutations that might affect viral 
replication impacting the capacity for viral infection in 
mosquitoes and primate hosts.(8,17) Thus, these viral par-
ticularities may have played a role in accelerating the dis-
semination and severity of the ongoing outbreak.
Climatic and environmental factors - Harvard sci-
entists in the 1990’s had already anticipated a dramatic 
global scenario for the next decades with global warm-
ing leading to proliferation and dislocation of mosquito 
vectors of arboviral diseases, as well as other vectors of 
infectious diseases, from tropical to temperate zones of 
the globe.(18-20) More recently, other ecologists of infec-
tious diseases(21,22) have noted that in temperate zones, 
where the winter temperature is very low for transmis-
sion of mosquito-borne infections, warmer summers can 
trigger the transmission and dislocation of these diseases 
into new areas, accelerating the parasite development 
rate and, thereby, making the region more suitable for 
the transmission of arboviral diseases. Another crucial 
climatic variable playing a crucial role on mosquito 
transmitted arbovirus besides temperature is rainfall by 
supplying suitable larval habitats.(23) The potential influ-
ence of variations in these climate variables in pathogen, 
vectors and reservoirs in ecological niches together with 
the possible impact of phenomena such as El Niño, La 
Niña and ecological disasters are complex and multi-
factorial, and their potential impact on the environment 
should be adequately understood. Finally, we empha-
size that ecosystems are increasingly being transformed 
into social ecosystems through human activity. Hence, 
prevalent theoretical frameworks and eco-social ap-
proaches must be reviewed.(24,25) Many factors related to 
anthropic environmental change, such as the extension 
of the agricultural frontier resulting from the expansion 
of agro-industry and other ecological disasters, prob-
ably have contributed to this spread. Further research is 
needed to evaluate the impact of environmental change, 
which includes new agricultural frontier expansion, on 
rapid YFV spread in the country. For instance, the so- 
called “MATOPIBA” territory, which comprises part of 
the Northeast Brazilian states of Maranhão, Tocantins, 
Piauí and Bahia, measuring about 400 thousand sq km 
(equivalent to the territory of Germany), has been the 
main area of expansion of the agricultural frontier in the 
last two decades.(26). MATOPIBA had a huge increase 
in grain production, mainly soybean, followed by wood 
devastation and traditionally extensive application of ag-
rochemicals. Possibly, part of the environmental change 
involving the components of the epidemiological chain 
of sylvatic YFV may have been affected by such recent 
agricultural expansion. The potential implications for 
YF outbreaks of other large environmental disasters in 
the country, such as the rupture of a mining dam in the 
city of Mariana, Minas Gerais, in 2015, are still contro-
versial and further research is imperative.
Mosquitoes: behavior and potential for domestic 
Aedes transmission - Climate change, which has most 
likely led to higher temperatures and rainfall in the re-
cent summer seasons, may have hypothetically favored 
an increase in mosquito population density in Brazil. 
Thus, higher mosquito biting rates exponentially in-
crease YFV circulation. The possibility of more efficient 
YFV vertical transmission in mosquitoes must also be 
considered. Mondet at al.(27) have suggested that vertical 
transmission is one of the key elements in the epidemiol-
ogy of YFV both in South America and Africa.
Fig. 3: probable route of spread of yellow fever (YF) epizootics of 1934-40 in Brazil as indicated by chronologic appearance of jungle YF. 
Sources: Benchimol(6) and Strode.(7) 
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Climatic and environmental conditions also favor 
mosquito transmission of the virus. Higher average tem-
peratures and rainfall enhance the population density of 
Aedini mosquitoes, such as Haemagogus and Aedes spe-
cies, by providing higher availability of larval habitats 
(mostly tree-holes and bamboo) and accelerating larval 
development, besides quickening viral replication and 
dissemination from the mosquito mid-gut to salivary 
glands. In Southeast Brazil, where the outbreak has 
spread, the rainy-hot season occurs essentially between 
November and May, which coincides with the peak of 
YFV cases and epizooties in 2016-2018.
Concerning the mosquito species vectors of sylvat-
ic YFV in the Southeast, a contrasting preference has 
been observed according to the vertical distribution in 
the forest. Two mosquito species have already been con-
firmed as YFV natural vectors during the ongoing out-
break in Southeast Brazil, Haemagogus leucocelaenus 
and Hg. janthinomys.(8) While Hg. janthinomys usually 
bites in much higher density at the tree canopies, Hg. 
leucocelaenus usually bites more frequently and shel-
ters at the forest ground level.(28) However, both species 
may bite both monkeys at the tree canopy and humans 
at the ground level upon entering or approaching the for-
est. Although both Haemagogus are active all day long, 
while Hg. leucocelaenus has a predominant afternoon 
biting activity, Hg. janthinomys usually reaches a bit-
ing peak around midday.(29) Although primatophilic, Hg. 
leucocelaenus and even Hg. janthinomys are eclectic 
concerning host preference biting other animals such as 
cattle, birds, dogs, rodents and horses, adapting to the 
modified environments.(30)
Degradation of natural habitats together with reduc-
tion of wild animal population size and consequent lack 
of blood source for sylvatic mosquito vectors has acceler-
ated recently, increasing human biting and the opportuni-
ties for vector sharing between NHPs and human beings. 
Besides degradation of natural environments, the death 
of NHPs due to YF may have led mosquitos to seek other 
blood sources, including humans, in the modified envi-
ronments, increasing the risk of human infection.
Recently, Evandro Chagas Institute in Brazil has pre-
liminarily reported the finding of YFV natural infection 
in Ae. albopictus captured in 2017 in rural areas near the 
municipalities of Itueta and Alvarenga in Minas Gerais.
(31) The detection of the YFV genome in a mosquito does 
not necessarily mean that the insect can play a vector 
role. Therefore, so far, it is not yet possible to refer to 
Ae. albopictus as a natural vector of YFV. However, Ae. 
albopictus populations from Brazil have proven to be 
competent to transmit the viruses although with much 
less efficiency than sylvatic vectors such as Hg. leucoce-
laenus and Sabethes albiprivus, simultaneously tested.
(32) Even being apparently poorly competent vectors, do-
mestic and peri-urban Brazilian Aedes, such as Ae. ae-
gypti and Ae. albopictus, may play an important role in 
YFV transmission given other conditions, such as high 
vector densities, high human-biting rate, high daily sur-
vival rates and low vaccination coverage. Couto-Lima et 
al.(32) note that considering all these conditions, it is diffi-
cult to understand why YF has not already reestablished 
an urban cycle in Brazil. Therefore, reducing domestic 
Aedes density in peri-urban and urban areas, with effec-
tive control policies(33) combined with rapid vaccination 
coverage are essential to avoid YFV transmission in ur-
ban centers close to enzootic areas. One recent study(34) 
found that Aedes are the predominant mosquitoes in 
nine public parks in the city of São Paulo.
Environmental policies and human behavior - An-
other factor that may help explaining the severity and 
rapid spread of the ongoing outbreak is the successful 
environmental and biodiversity protection policies of 
IBAMA (the Brazilian Agency for Environmental Pro-
tection) which has led to a considerable increase in the 
number of conservation units and legal actions to protect 
Brazilian fauna with its very strict wildlife preservation 
measures during the last decades. The total accumulat-
ed area held by conservation units in Brazil has been 
greatly enlarged since the last severe YFV outbreak in 
the Southeast, consisting of 218,081ha in 1930-1940 to 
76,848,771ha by 2009, an increase of 361.5%.(35) Togeth-
er, these measures and policies progressively and consid-
erably expanded the areas with environmental and eco-
logical conditions to support mosquito species diversity 
and abundance as well as the NHP population growth 
and recolonisation of sites previously reporting extinc-
tions for decades in the Southeast region which has been 
affected by the YFV since late 2016. Formerly, exten-
sive forests have reduced in size or been altered due to 
expanding agriculture, livestock and peri-urban growth 
in the Southeast. But, wood fragments enhanced in size 
and wild corridors such as gallery forests have gradually 
recovered during the last decades favoring even more 
the conditions for proliferation and dispersion of arbo-
real mosquitoes and NHPs, and consequently arbovirus 
transmission. Simultaneously and following the example 
of what has been happening in the world in terms of hu-
man way of life and practices, the interest in living in, 
experiencing and interacting with the natural environ-
ment and especially the forest has increased consider-
ably, particularly at the outskirts of the largest south-
eastern Brazilian cities under influence of the Atlantic 
forest biome. The vogue of eco-tourism and the rise of 
some human practices related to the woods such as the 
so-called back to nature movement, neo-survivalism 
and sylvotherapy have been reported. Living or having a 
secondary dwelling in or near the forest became one of 
the aspirations of contemporary man. These life styles 
and practices have led people to an increasing approach 
to the woods and the sylvatic transmission cycles of in-
fectious agents in the Atlantic forest. Therefore, the risk 
of zoonotic infections has been higher than ever, as il-
lustrated by the malaria outbreaks of simian origin re-
corded in this biome of Southeastern Brazil in the last 
years.(36) Coincidently, YFV and Plasmodium simium, 
the causative agent of these malaria outbreaks, share the 
same vertebrate hosts, the NHPs, particularly howler 
monkeys. Yet, these philosophical human approaches to 
the woods as any other anthropic modification (e.g., ag-
ricultural expansion and environmental disasters) result 
in degradation of original habitats of NHPs and mosqui-
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toes which in turn will be forced to exploit the ecotone 
between the natural and modified environment and even 
migrate between patches of woods, favoring viral dis-
persion. In conclusion, a combination of several factors 
concerning human behavior and environmental policies 
have also contributed to recently transform the coastal 
zone of the Southeast region more receptive and vulner-
able to sylvatic YFV transmission and accidental human 
infection in this cycle.
NHPs: restricted mobility in YFV spread
The susceptibility of NHPs to the YFV is quite vari-
able and seems to depend upon at least two-way interac-
tions between the NHP population and virus strain.(7) Al-
though susceptible to the YFV infection, African NHPs 
are resistant to the disease which makes it difficult to iso-
late the virus from wild-caught animals in the continent 
where the YFV originated. Indeed, the first isolation of 
YFV from infected humans could not be achieved in Af-
rican NHPs until the inoculation of Indian Rhesus ma-
caques.(37) On the other hand, Neotropical NHP species 
are in general susceptible to YFV infection and disease. 
Examining 5,800 Brazilian NHP serum samples for neu-
tralising antibodies, Kumm and Laemmert(38) reported 
that immune primates of essentially all genera have been 
found almost everywhere in the country although anti-
body prevalence varies not only according to area, but 
particularly with the NHP genus. A recent study reports 
the presence of anti-YFV antibodies in howler monkeys 
(Alouatta) captured many months after a YFV outbreak.
(39) Pathogenicity and viraemia (length and viral load) 
vary according to Neotropical NHP species, which in 
turn, considerably determines their role as a virus ampli-
fier host in Brazil. Some species may have a prolonged 
host status for the virus as howler monkeys and marmo-
sets.(40,41) In general, mortality in howler monkeys (genus 
Alouatta) and marmosets (genus Callithrix) is high while 
the capuchin monkeys (Cebus and Sapajus) seem to have 
intermediate susceptibility to the disease. Monkey mor-
tality due to YFV in Brazil is considerably concentrated 
in howler monkeys (Alouatta). Their role in the sylvatic 
cycle is so dominant that their sudden silence and deaths 
in the woods serves as a signal to local inhabitants and 
health authorities for the circulation of the virus.(42) How-
ever, marmosets also play an important role. According 
to Waddell and Taylor,(40) Callithrix penicillata and its 
hybrids with other marmoset species and even for Le-
ontopthecus chrysomelas were very susceptible to the 
Almada YFV strain in Ihéus, Bahia state. The same au-
thors report that a YFV strain of sylvatic origin was eas-
ily maintained by alternate passage through Callithrix 
aurita and Ae. aegypti mosquitoes, also achieved with a 
capuchin monkey species (Cebus versutus) though pre-
senting lower mortality.
In the last four decades, the exacerbated degradation 
of some Brazilian natural environments has accelerated 
deforestation with the use of fire and big machines, de-
stroying enormous areas of the inland forests. When los-
ing their natural habitats, some NHP species have been 
forced to relocate and inhabit modified environments and 
suffer overpopulation of small patches of forest. Alto-
gether, (i) augmentation of conservation areas combined 
with successful biodiversity protection policies; (ii) high 
population density of non-immune NHP in the coastal 
Southeast; and (iii) increased occupation of the modified 
environment by adapted NHPs such as marmosets and 
capuchin monkeys in Haemagogus infested woods have 
favored the spread of the sylvatic YFV epizootic waves to 
this region and consequently, human infection. However, 
more research is necessary to understand the mechanism 
by which YFV could travel such vast geographical ex-
tensions, so rapidly, as we are witnessing in the ongoing 
outbreak. It has been suggested that the YFV had an av-
erage dispersal of around 3 km per day in the Southeast 
since early 2017.(8,43) In a previous outbreak in the South, 
the trajectory of the yellow fever virus circulation was 
estimated at 600 km in six months.(39)
There is a consensus among experts, in spite of the 
susceptibility to the YFV infection of some Neotropical 
genera (e.g., Alouatta and Callithrix), NHPs are not re-
sponsible for such a rapid spread of the YFV. All available 
knowledge about habits of Southeastern NHP species in-
dicates that their home ranges and daily travelling range 
in forests are usually restricted, and they normally do not 
use the ground and deforested areas to migrate from one 
place to another, except under extenuating circumstanc-
es.(44) Thus, it is highly unlikely that NHPs would carry 
the infection over long distances. On the other hand, 
infected mosquitos and humans can disperse the virus 
over great distances.(12,16,45) For instance, sylvatic YFV 
vectors such as Haemagogus mosquitoes may disperse 
several kms from a releasing point, a contrasting behav-
ior with that of Sabethes mosquitoes, secondary sylvatic 
YFV vectors, where flight is usually restricted to the 
forest and near surroundings.(45,46) In fact, Causey et al.(45) 
demonstrated that females of the mosquito species, now-
adays referred to as Hg. janthinomys/capricornii and Hg. 
leucocelaenus, could be collected 11.5 km and 5.7 km, 
respectively, from a releasing forest in Southeast Brazil 
in few days. During the course of this long displacement, 
Haemagogus mosquitoes may almost continuously tra-
verse large areas of pasture and vast monoculture plan-
tations as well as visit scattered gallery forests and re-
sidual forest patches. In other words, these mosquitoes 
are liable to span long distances beyond the forest where 
they emerged from their original arboreal larval habitat, 
a pattern also observed in Central Brazil.(47,48) Of course, 
this behavior greatly favors continuous viral spread at 
long distances across these mosquito territories. Female 
mosquito dispersal is essentially governed by the search 
for oviposition sites and blood sources, and dispersal ad-
vantageously reduces genetic structuring of the popula-
tion. Several factors may influence Haemagogus female 
mosquitoes from climatic (low rainfall leading to reduc-
tion of spatial availability of water-containing tree-holes 
stimulating dispersal and vice-versa) to environmental 
and ecological conditions. In the latter two cases, reduc-
tion of NHP’s and other wild animal populations’, as a 
consequence of natural habitat degradation and deaths 
by YFV, has led to a reduction of blood sources, thus 
inducing sylvatic mosquito dispersion. In addition to the 
intrinsic mosquito flight ability, it has been shown that 
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convection currents around twilight aid arboreal mos-
quitoes to disperse between isolated patches of woods.
(7,48) Thus, any factor influencing mosquito dispersal 
would increase the risk of human biting and infections.
During the ongoing outbreak in the state of Rio de 
Janeiro two examples of fast and far YFV dispersal can 
be respectively illustrated by the unexpected sudden hu-
man and NHP deaths in the districts of Maricá and Ilha 
Grande (an island) just after the beginning of the 2017 
and 2018 transmission seasons were recorded in the state. 
The main and large YFV generating foci and dissemi-
nation areas in the state has mostly been the denser for-
ests growing on escarpments of the Serra do Mar, a long 
system of mountain ranges parallel to the Atlantic Ocean 
coast.(8) Maricá has considerably small wood fragments 
poorly connected by scattered remains of gallery for-
ests to the Serra do Mar around 20 km apart, while Ilha 
Grande is separated from the continent by more than 2 
km of sea. It is inconsistent to attribute such efficient dis-
persions of the YFV to NHPs, whereas the displacement 
of paucisymptomatic and asymptomatic humans and/or 
infected mosquitoes may better explain the phenomena. 
These evidences suggest that NHPs may have a reduced 
contribution to the rapid spread of the ongoing outbreak.
YF asymptomatic human mobility
Only few YFV infected people become ill and de-
velop symptomatic disease, thus the majority are as-
ymptomatic. Viremic paucisymptomatic or asymp-
tomatic individuals accidentally infected by the bite of 
sylvatic mosquitoes can travel carrying the YFV and 
rapidly disseminate the infection to distant receptible 
areas, i.e., sites infested by competent mosquito vectors. 
Receptive sites may vary from forest patches, their sur-
roundings, rural areas and microenvironments within 
urban areas supporting wildlife with propensity to ex-
ploit variable environments (or overlap territory with 
synathropic species) occupied or reachable by Haema-
gogus and/or Sabethes mosquitoes as well as peri-urban 
and urban areas densely infested by Ae. aegypti and Ae. 
albopictus populations competent to transmit the YFV. 
The current increasing number of people who move to 
and from areas of risk in the Atlantic Forest biome has 
probably favored the rapid spread of the ongoing Haem-
agogus vectored YFV outbreak into urban and peri-ur-
ban ecosystems, which has increasingly jeopardised the 
reemergence of Aedes transmission in the peri-urban/
urban areas, now a great concern.
Until very recently, YFV was usually acquired by 
unvaccinated people from the YF free area along the 
Brazilian coast when visiting the enzootic and epizootic 
inland Cerrado and Amazon biomes for tourism or work. 
The incidence of such YFV infections had been low, and 
thus, the risk of reemergence of Aedes transmitted YFV 
in the anthropic environment was reduced before the on-
going outbreak reached the large and highly populated 
coastal Southeast region. Since the virus and the clinical 
evolution are identical, there is no distinction between 
“sylvatic yellow fever” and “urban yellow fever” except 
for the ecological nature of the transmission, more prop-
erly defined by the type of vector mosquito. Currently, 
even the geographical location of infection acquisition 
could not suitably define a case as a sylvatic or urban 
yellow fever event. Indeed, there has been a recent in-
creasing expansion of urbanisation in the Southeast with 
the continuous construction of urbanised neighborhoods 
and other types of settlements in areas bordering the en-
zootic forest attainable by YFV sylvatic mosquito vector 
flight. Thus, an infection acquired by someone living in 
a house or visiting a park in an urbanised area near an 
epizootic patch of wood increasingly deserves a deep ep-
idemiological investigation concerning the origin, since 
Haemagogus mosquitoes may bite far from the wild on 
even indoors.(47) In addition, the overlapping territories 
of confirmed and potential YFV vectors have expanded 
in Southeast and South Brazil favoring human infection 
by the bite of sylvatic mosquitoes (Haemagogus and Sa-
bethes) but also potentialising enzootic spillovers with 
establishment of YFV either into an intermediate/rural 
cycle, due to the ecological plasticity of the invader mos-
quito Ae. albopictus, or into a potential urban cycle with 
limited transmission between the domestic mosquito Ae. 
aegypti and humans (Fig. 4).
In conclusion, although yellow fever viremia is usu-
ally short in humans, the possibility of intense mobil-
ity of infected but asymptomatic people participating in 
the virus spread chain is more real than ever, with the 
increasing overlap between sylvatic and urban ecosys-
tems, in a transition ecological zone (Fig. 4).
The dislocation of asymptomatic YFY viremic 
people has implications not only for viral spread within 
Brazil and receptive South American areas but also for 
global dissemination. The risk of YFV spread in global 
travels is very high and the reason is that the world has 
annually higher number of air passengers than ever. 
According to the UN World Tourism Office, Asia and 
the Pacific (both infested by Ae. aegypti) is expected to 
witness the strongest growth in tourist arrivals, where 
the forecast suggests an increase by 331 million over 
the 2010-30 period to reach 535 million in 2030, with 
a growth of 4.9% per year.(49) The recent YF spread via 
unvaccinated travelers from Angola to China highlights 
this threat, indicating how individuals can still circum-
vent the International Health Regulations.(50,51) This sce-
nario highlights the need for permanent international 
vaccination requirements and molecular surveillance of 
YFV strains from different regions of the globe.
Response: need to extend vaccine coverage, R & D 
and production
Historically, increased governmental demands for 
vaccines have emerged at the peaks of YFV outbreaks 
or epidemics, which have not been met due to signifi-
cant vaccine shortages caused by the insufficient federal 
investments in the main global public manufacturer and 
exporter of the YF vaccine, Bio-Manguinhos/Fiocruz. 
This scenario resulted recently in a governmental deci-
sion for fractional YF vaccine doses in Brazil, as wit-
nessed in Africa in the last outbreak in Angola, which 
spread to the Democratic Republic of Congo.(52,53)
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Availability: YF vaccine shortages and fractional doses
Availability of YF vaccines is a major issue for ex-
tending immunisation coverage to the whole Brazilian 
population. The need to overcome YF vaccine shortages 
has been historically a concern of Brazilian authorities 
since the early outbreak in 1988 and later in 2008 when 
the sudden increase in the demand for YFV vaccines 
forced Bio-Manguinhos to discontinue exportation to 
other countries. The Brazilian Ministry of Health enlist-
ed Bio-Manguinhos for a dose-response study with the 
produced YFV vaccine in order to verify immunogenic-
ity and safety in formulations with lower doses of the 
17DD-YFV. The results of this study, conducted by Bio-
Manguinhos researchers(54) indicated that immunoge-
nicity of vaccine formulations with 587 IU or more per 
dose is similar to the 27,476 IU dose currently applied 
for short and mid-term protection. There were no differ-
ences among groups regarding common adverse events, 
with exception of pain, found more frequently with the 
larger dose, reference vaccine. There were no difference 
among groups regarding proportion or intensity of vire-
mias detected by viral plaque formation or quantitative 
real-time-PCR (qRT-PCR). Seropositivitity of those who 
seroconverted was maintained during eight years, with 
no differences among groups.(55) A recent study(56) has 
advanced evidence base supporting these results.
Considering also the excellent data for vaccine sta-
bility observed during the study, it would no longer be 
justifiable to keep the high dose in current use as a stan-
dard in the adult population. Final considerations were 
adopted, stressing that changes in vaccine formulation 
would require confirmation of these results in infants, 
the target population for vaccination in endemic areas. 
Conclusions of the studies support feasibility of frac-
tional doses as proposed by WHO directives.(57) Bio-
Manguinhos is the only manufacturer using the 17DD 
substrain in an effort for vaccine sparing. The need to 
significantly increase Bio-Manguinhos production of 
YF vaccine to meet this sharp increase in demand for the 
vaccine from Brazil and other countries is clear. Finally, 
it is important to highlight that fractional doses of YF 
vaccine are not yet compliant with International Health 
Regulations (IHR) and therefore should be used only in 
outbreak settings until we have more data.
The WHO Global Strategy to Eliminate Yellow fe-
ver Epidemics - EYE(58) supports the need to increase 
global vaccine coverage and the production of the main 
manufacturers, such as Bio-Manguinhos. This global 
strategy has defined goals that should be urgently met 
by Brazil and other Latin American and Caribbean 
countries (LAC). One of the key milestones of this strat-
egy establishes that by the end of 2021 all LAC should 
have completed mass immunisation campaigns. In order 
Fig. 4: yellow fever virus (YFV) transmission dynamics in Atlantic Forest biome: overlap of ecosystems and ecotone. In the last decades, the 
progressive combination of several factors has contributed to gradually expand the overlap of ecosystems (sylvatic and anthropic) and the eco-
tone as well as to imbricate the Haemagogus-vectored YFV cycle and the territory of synathropic species, facilitating YFV expansion, human 
infections and increasingly jeopardised the reemergence of Aedes transmission in the urban areas. Among those factors are: (a) the augmentation 
of areas with environmental and ecological conditions to support mosquito and non-human primate (NHP) diversity and population growth due 
to the success of recent environmental policies; (b) the loss of some natural habitats forcing NHPs (e.g., marmosets, capuchins) to exploit the 
ecotone and the modified environments and their overpopulation of remaining forest fragments; (c) adoption of new life styles and practices by 
the contemporary man leading to an increasing approach to the woods; (d) rapid and intense human displacements; (e) the ecological plasticity 
of vectors, specially the liability of Haemagogus to span long distances beyond the forest limits and Ae. albopictus to colonise and disperse 
from the modified into the sylvatic ecosystem; (f) the crescent infestation rates by Ae. aegypti in expanding urban and peri-urban areas near the 
Haemagogus-transmitted YFV cycle.
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to meet this goal, a significant increase in vaccine pro-
duction and availability must be provided by Brazil and 
other countries in the LAC region. The global supply of 
YF vaccines is expected to increase to between 116 and 
159 million doses in 2021, and to between 162 and 183 
million doses in 2026. The increased capacity expected 
during 2017-2020 should be achieved by prioritising 
and optimising YF vaccine production and contracting 
manufacturer operations for filling and freeze-drying. 
New production capacity is mainly expected after 2021, 
when new facilities in two manufacturers will start pro-
duction.
Coverage issues: adverse effects and vaccine refusal
A recent study(59) has provided an overview of global 
YF vaccination coverage from 1970 to 2016, based on 
adjusted retrospective analysis, indicating the urgent 
need to increase global coverage of the YF vaccine. It 
was estimated that between 303.7 million and 472.9 mil-
lion people leaving in areas at risk of YFV transmission 
still require vaccination to achieve the 80% population 
coverage threshold recommended by WHO. This repre-
sents 43-52% of populations in YF zones, compared with 
the population who would have required vaccination in 
1970. Nevertheless, it is important to note that besides 
economic and policy constraints, there are behavioral 
obstacles to meet this goal. One of the main reasons is 
that individuals feel safe when they are in urban and 
peri-urban areas or even in rural zones when they do 
not enter the forest. Even if they work or recreate on the 
open fields attend clubs, resorts and parks, in or outside 
the forest ecotone, their perception of risk of acquire the 
YFV is very low, because they are usually not convinced 
that they are potentially exposed to YFV infected mos-
quito bites (Fig. 4). This perception of low risk combined 
with their exacerbated perception of adverse effects of 
YF vaccine consists of an important hindrance for the 
achievement of the optimal vaccination coverage.
On 25 January 2018, Brazilian health authorities 
began a vaccination campaign (fractional and standard 
doses) targeting 69 municipalities in Rio de Janeiro (10 
million persons in 15 municipalities) and São Paulo (10.3 
million in 54 municipalities) states. As of 16 February 
2018, preliminary results of the mass YF vaccination 
campaign indicated that 4.3 million persons had been 
vaccinated for YF (3.9 million persons with fractional 
doses and 379,987 persons with standard doses).(60) This 
represents 21% of the planned coverage of over 20 mil-
lion people targeted for vaccination in the two men-
tioned states. Due to the low vaccination rate achieved 
during the campaign in Rio de Janeiro state (12.1% of the 
targeted population), state health authorities extended 
the campaign. Similarly, in São Paulo state, only 29.6% 
of the targeted population had been vaccinated during 
the campaign and state health authorities are assessing 
whether or not to extend the campaign.(61,62) To widen this 
very low vaccine coverage in the campaign, the states 
of Rio de Janeiro and São Paulo decided to continue the 
population vaccination strategy with support of the Min-
istry of Health. Preliminary YF immunisation data sent 
to the Brazilian Ministry of Health by the Health Secre-
tariats of the states of Bahia (55% of target population), 
Rio de Janeiro (71% of target population) and São Paulo 
(90% of target population) indicate that this coverage has 
significantly improved since the beginning of the cam-
paign with 17,300,000 people vaccinated. But the cover-
age is still low and additional efforts and more proactive 
initiatives should be taken with support of the educa-
tional system and more effective media communication 
strategies to extend YF vaccine coverage to the whole 
Brazilian population. It is important to note that one of 
the main issues for this low vaccination rate are not only 
related to the availability of YF vaccines but to vaccine 
refusal, particularly in more affluent groups, related to 
exacerbated perception of the vaccine adverse effects 
from erroneous information disseminated through so-
cial media and networks in the internet as well as mis-
understanding of the effectiveness of fractional doses.
Immunisation of NHPs: monitored areas
The immunisation of NHPs should also be a priority 
for animals confined in parks and forest reserves con-
tiguous to urban areas as well as animals maintained in 
captivity in research centers and zoos where the monkey 
population is monitored and thus immunisation feasible. 
Immunogenicity studies with the 17D vaccine have only 
been conducted in the Indian Rhesus macaque.(63) Anti-
body response in monkeys inoculated with graded doses 
of the 17D vaccine was subject to pioneer studies in the 
1970’s.(63,64) No similar studies on howler monkeys or 
any other very susceptible and efficient amplifier hosts 
have ever been carried out. Although it is impossible 
at this stage to recommend 17DD / 17D vaccination of 
howler monkeys and other NHPs, there is an urgent need 
to accelerate safety and immunogenicity studies with 
the 17D vaccine in such Neotropical hosts, especially 
howler monkeys, which should be expedited in regula-
tory procedures due to the YF emergency. Although the 
experimental immunisation of monkeys would greatly 
diminish the sentinel role NHPs play in such selected 
confined areas, it would significantly reduce viral circu-
lation in risk areas besides preserving biodiversity and 
protecting endangered species in conservation areas. In 
fact, local NHP populations may be extinct or greatly re-
duced as a consequence of devastating YFV epizooties.
(7,65,66) Although controversies among primatologists on 
the feasibility of NHP immunisation have come to light, 
considering potential difficulties in capture and/or vac-
cine injection in free-living animals in the open fields 
due to their high mobility, novel technological strategies 
for immunisation should be conceived and evaluated in 
Brazil. Many potential technological approaches could 
be adopted for such immunisation such as food con-
taining recombinant vaccine, transgenic fruit and other 
technological alternatives. Of course, these possibilities 
must be very well discussed with people involved in the 
preservation of NHPs, environmental experts, scientists 
and governmental bodies for an adequate financial sup-
port. A pilot study with existing 17DD YF vaccine in 
Golden-headed lion tamarins - GHLT (Leontopithecus 
chrysomelas) and howler monkeys (Alouatta sp) is cur-
rently in progress at Bio-Manguinhos/Fiocruz in col-
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laboration with the Rio de Janeiro Primatology Center. 
Although YF has not sufficiently been studied in Neo-
tropical NHPs and there is no current proven vaccina-
tion for NHPs, there are operational difficulties to apply 
traditional needle immunisation strategies in this popu-
lation due to high monkey mobility. It is therefore neces-
sary to advance and develop the above mentioned novel 
monkey immunisation delivery strategies. This type of 
initiative must be supported by awareness of the benefi-
cial role of NHPs as a sentinel of YFV circulation and 
not as direct disseminators of the YF etiological agent 
harmful to the human population. During the 2008-2009 
YFV outbreak in Rio Grande do Sul, South region, mis-
information resulted in aggression towards monkeys and 
even extermination(67) leading to the local red howler to 
be once again listed as an endangered species in Brazil. 
A similar situation has occurred in the Southeast region 
where some of the most endangered NHP species living 
on the continent have already been greatly reduced in 
the Atlantic Forest. In fact, misinformation has created a 
negative image of the NHP in public opinion.
Final considerations
For decades, Brazilian scientists have been warning 
the public health authorities that once the virus started 
to circulate in the Atlantic Forest biome close to large 
metropolitan areas, the risk of reurbanisation of a dis-
ease, so far limited to the sylvatic cycle in the endemic/
enzootic Amazon Forest and the inland Cerrado biomes, 
would become more real than ever. The recent territo-
rial dislocation of the YFV has not been linear. As in 
previous large sylvatic outbreaks it has taken place in 
complex and multiple pathways, in epizootic waves 
combined with the unprecedented intense mobility of 
asymptomatic infected humans involved in rural work, 
eco-tourism, extrativism and animal traffic. A second 
reason for this concern is the possibility of a catastrophic 
event affecting a huge number of non-vaccinated people 
as confirmed by the current outbreak. The complex epi-
demiological patterns of the disease dissemination have 
detrimentally combined with the very low vaccination 
coverage of the population in the main metropolitan ar-
eas, which persists even after the ongoing YF outbreak, 
together with the inefficient Ae. aegypti control measures 
in peri-urban and urban areas. Moreover, despite recent 
advances in understanding the eco-social determinants 
involved in the rapid spread of the ongoing outbreak, 
several knowledge gaps still persevere. The hypothesis 
of the possible role of asymptomatic infected humans 
in YF outbreaks in Brazil requires further research. As 
well, the mechanisms underlying the rapid spread of epi-
zootics in the country must be understood. Epidemio-
logical parameters to provide support to these hypoth-
eses will be necessary. Many issues related to molecular 
epidemiology and transmission cycles of YFV in the di-
verse Brazilian biomes remain poorly understood. Sup-
port for research and development activities in this field 
is urgently needed, promoting innovative governance 
strategies with targeted investments aiming to improve 
surveillance and fast response to the epidemics. Immun-
isation coverage of the Brazilian population living in the 
affected areas should urgently target the entire popula-
tion in order to minimise the impact of the ongoing out-
break.(68) Novel monkey immunisation strategies are also 
crucial in parks, preservation areas and zoos, avoiding 
extinction of species at risk and preserving biodiversity. 
Finally, it is imperative to continuously monitor YFV re-
ceptivity and vulnerability conditions, strengthening the 
National Laboratory Network for YF diagnosis, in order 
to improve the quality of response and prevent future 
outbreaks possibly leading to catastrophic reurbanisa-
tion of the infection in Brazil and other Latin American 
and Caribbean countries.
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